|
1
|
Singh S and Chellappan S: Lung cancer stem
cells: Molecular features and therapeutic targets. Mol Aspects Med.
39:50–60. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yan X, Luo H, Zhou X, Zhu B, Wang Y and
Bian X: Identification of CD90 as a marker for lung cancer stem
cells in A549 and H446 cell lines. Oncol Rep. 30:2733–2740. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Akunuru S, Zhai James Q and Zheng Y:
Non-small cell lung cancer stem/progenitor cells are enriched in
multiple distinct phenotypic subpopulations and exhibit plasticity.
Cell Death Dis. 3:e3522012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Meacham CE and Morrison SJ: Tumour
heterogeneity and cancer cell plasticity. Nature. 501:328–337.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dionne LK, Driver ER and Wang XJ: Head and
neck cancer stem cells: From identification to tumor immune
network. J Dent Res. 94:1524–1531. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Herzenberg LA, Parks D, Sahaf B, Perez O,
Roederer M and Herzenberg LA: The history and future of the
fluorescence activated cell sorter and flow cytometry: A view from
Stanford. Clin Chem. 48:1819–1827. 2002.PubMed/NCBI
|
|
7
|
Xu Y, Zhao W, Wu D, Xu J, Lin S, Tang K,
Yin Z and Wang X: Isolation of myeloid-derived suppressor cells
subsets from spleens of orthotopic liver cancer-bearing mice by
fluorescent-activated and magnetic-activated cell sorting:
Similarities and differences. Int J Clin Exp Pathol. 7:7545–7553.
2014.PubMed/NCBI
|
|
8
|
Izumiya M, Kabashima A, Higuchi H,
Igarashi T, Sakai G, Iizuka H, Nakamura S, Adachi M, Hamamoto Y,
Funakoshi S, et al: Chemoresistance is associated with cancer stem
cell-like properties and epithelial-to-mesenchymal transition in
pancreatic cancer cells. Anticancer Res. 32:3847–3853.
2012.PubMed/NCBI
|
|
9
|
Vaughan MB, Ramirez RD, Wright WE, Minna
JD and Shay JW: A three-dimensional model of differentiation of
immortalized human bronchial epithelial cells. Differentiation.
74:141–148. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kucerova L, Feketeova L, Kozovska Z,
Poturnajova M, Matuskova M, Nencka R and Babal P: In vivo
5FU-exposed human medullary thyroid carcinoma cells contain a
chemoresistant CD133+ tumor-initiating cell subset. Thyroid.
24:520–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang A, Chen L, Pu K and Zhu Y:
Identification of stem-like cells in non-small cell lung cancer
cells with specific peptides. Cancer Lett. 351:100–107. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schaefer-Prokop C, Prosch H and Prokop M:
Lung cancer screening: What have we learnt for the practice so far?
Radiologe. 54:462–469. 2014.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Spira A, Halmos B and Powell CA: Update in
lung cancer 2014. Am J Respir Crit Care Med. 192:283–294. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Anglim PP, Alonzo TA and Laird-Offringa
IA: DNA methylation-based biomarkers for early detection of
non-small cell lung cancer: An update. Mol Cancer. 7:812008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ettinger DS, Wood DE, Akerley W, Bazhenova
LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA,
Demmy TL, et al: Non-small cell lung cancer, Version 6. 2015. J
Natl Compr Canc Netw. 13:515–524. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kalemkerian GP, Akerley W, Bogner P,
Borghaei Hossein, Chow LQ, Downey RJ, Gandhi L, Ganti P AK,
Govindan R, Grecula JC, et al: Small cell lung cancer. J Natl Compr
Canc Netw. 11:78–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alison MR, Lin WR, Lim SM and Nicholson
LJ: Cancer stem cells: In the line of fire. Cancer Treat Rev.
38:589–598. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Giangreco A, Arwert EN, Rosewell IR,
Snyder J, Watt FM and Stripp BR: Stem cells are dispensable for
lung homeostasis but restore airways after injury. Proc Natl Acad
Sci USA. 106:9286–9291. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lathia JD, Mack SC, Mulkearns-Hubert EE,
Valentim CL and Rich JN: Cancer stem cells in glioblastoma. Genes
Dev. 29:1203–1217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gawlik-Rzemieniewska N and Bednarek I: The
role of NANOG transcriptional factor in the development of
malignant phenotype of cancer cells. Cancer Biol Ther. 17:1–10.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fulawka L, Donizy P and Halon A: Cancer
stem cells-the current status of an old concept: Literature review
and clinical approaches. Biol Res. 47:662014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ucar D, Cogle CR, Zucali JR, Ostmark B,
Scott EW, Zori R, Gray BA and Moreb JS: Aldehyde dehydrogenase
activity as a functional marker for lung cancer. Chem Biol
Interact. 178:48–55. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tirino V, Camerlingo R, Bifulco K, Irollo
E, Montella R, Paino F, Sessa G, Carriero MV, Normanno N, Rocco G
and Pirozzi G: TGF-β1 exposure induces epithelial to mesenchymal
transition both in CSCs and non-CSCs of the A549 cell line, leading
to an increase of migration ability in the CD133+ A549 cell
fraction. Cell Death Dis. 4:e6202013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ahmadipour F, Noordin MI, Mohan S, Arya A,
Paydar M, Looi CY, Keong YS, Siyamak EN, Fani S, Firoozi M, et al:
Koenimbin, a natural dietary compound of murraya koenigii (L)
spreng: Inhibition of MCF7 breast cancer cells and targeting of
derived MCF7 breast cancer stem cells (CD44(+)/CD24 (-/low)): An in
vitro study. Drug Des Devel Ther. 9:1193–1208. 2015.PubMed/NCBI
|
|
29
|
Chang Y, Zhao Y, Gu W, Cao Y, Wang S, Pang
J and Shi Y: Bufalin inhibits the differentiation and proliferation
of cancer stem cells derived from primary osteosarcoma cells
through Mir-148a. Cell Physiol Biochem. 36:1186–1196. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Keysar SB and Jimeno A: More than markers:
Biological significance of cancer stem cell-defining molecules. Mol
Cancer Ther. 9:2450–2457. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
White A and Swanson SJ: Minimally invasive
surgery for early-stage lung cancer: From innovation to standard of
care. Oncology (Williston Park). 30:982–987. 2016.PubMed/NCBI
|
|
32
|
Gazdar AF, Girard L, Lockwood WW, Lam WL
and Minna JD: Lung cancer cell lines as tools for biomedical
discovery and research. J Natl Cancer Inst. 102:1310–1321. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Damhofer H, Ebbing EA, Steins A, Welling
L, Tol JA, Krishnadath KK, van Leusden T, van de Vijver MJ,
Besselink MG, Busch OR, et al: Establishment of patient-derived
xenograft models and cell lines for malignancies of the upper
gastrointestinal tract. J Transl Med. 13:1152015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rubin H: Multistage carcinogenesis in cell
culture. Dev Biol (Basel). 106(61–67): 143–160. 2001.
|
|
35
|
Jones MF, Hara T, Francis P, Li XL, Bilke
S, Zhu Y, Pineda M, Subramanian M, Bodmer WF and Lal A: The
CDX1-microRNA-215 axis regulates colorectal cancer stem cell
differentiation. Proc Natl Acad Sci USA. 112:E1550–E1558. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang K, Zeng J, Luo L, Yang J, Chen J, Li
B and Shen K: Identification of a cancer stem cell-like side
population in the HeLa human cervical carcinoma cell line. Oncol
Lett. 6:1673–1680. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Van den Broeck A, Vankelecom H, Van Delm
W, Gremeaux L, Wouters J, Allemeersch J, Govaere O, Roskams T and
Topal B: Human pancreatic cancer contains a side population
expressing cancer stem cell-associated and prognostic genes. PLoS
One. 8:e739682013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen X, Chen D, Yang S, Ma R, Pan Y, Li X
and Ma S: Impact of ABCG2 polymorphisms on the clinical outcome of
TKIs therapy in Chinese advanced non-small-cell lung cancer
patients. Cancer Cell Int. 15:432015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Goodell MA, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp Med.
183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Salcido CD, Larochelle A, Taylor BJ,
Dunbar CE and Varticovski L: Molecular characterization of side
population cells with cancer stem cell-like characteristics in
small-cell lung cancer. Br J Cancer. 102:1636–1644. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wu C and Alman BA: Side population cells
in human cancers. Cancer Lett. 268:1–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jiang F, Qiu Q, Khanna A, Todd NW, Deepak
J, Xing L, Wang H, Liu Z, Su Y, Stass SA and Katz RL: Aldehyde
dehydrogenase 1 is a tumor stem cell-associated marker in lung
cancer. Mol Cancer Res. 7:330–338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu J, Xiao Z, Wong SK, Tin VP, Ho KY,
Wang J, Sham MH and Wong MP: Lung cancer tumorigenicity and drug
resistance are maintained through ALDH(hi)CD44(hi) tumor initiating
cells. Oncotarget. 4:1698–1711. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Okudela K, Woo T, Mitsui H, Suzuki T,
Tajiri M, Sakuma Y, Miyagi Y, Tateishi Y, Umeda S, Masuda M and
Ohashi K: Downregulation of ALDH1A1 expression in non-small cell
lung carcinomas-its clinicopathologic and biological significance.
Int J Clin Exp Pathol. 6:1–12. 2013.PubMed/NCBI
|
|
45
|
Meng X, Wang X and Wang Y: More than 45%
of A549 and H446 cells are cancer initiating cells: Evidence from
cloning and tumorigenic analyses. Oncol Rep. 21:995–1000.
2009.PubMed/NCBI
|
|
46
|
Willerson JT: CD133+ stem cells in the
treatment of patients with refractory angina. Circ Res.
120:602–603. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yi H, Cho HJ, Cho SM, Jo K, Park JA, Lee
SH, Chang BJ, Kim JS and Shin HC: Effect of 5-FU and MTX on the
expression of drug-resistance related cancer stem cell markers in
non-small cell lung cancer cells. Korean J Physiol Pharmacol.
16:11–16. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang HZ, Lin XG, Hua P, Wang M, Ao X,
Xiong LH, Wu C and Guo JJ: The study of the tumor stem cell
properties of CD133+CD44+ cells in the human lung adenocarcinoma
cell lineA549. Cell Mol Biol (Noisy-le-grand). 56
Suppl:OL1350–OL1358. 2010.PubMed/NCBI
|
|
49
|
Roudi R, Madjd Z, Ebrahimi M, Samani FS
and Samadikuchaksaraei A: CD44 and CD24 cannot act as cancer stem
cell markers in human lung adenocarcinoma cell line A549. Cell Mol
Biol Lett. 19:23–36. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nakatsugawa M, Takahashi A, Hirohashi Y,
Torigoe T, Inoda S, Murase M, Asanuma H, Tamura Y, Morita R,
Michifuri Y, et al: SOX2 is overexpressed in stem-like cells of
human lung adenocarcinoma and augments the tumorigenicity. Lab
Invest. 91:1796–1804. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sung JM, Cho HJ, Yi H, Lee CH, Kim HS, Kim
DK, Abd El-Aty AM, Kim JS, Landowski CP, Hediger MA and Shin HC:
Characterization of a stem cell population in lung cancer A549
cells. Biochem Biophys Res Commun. 371:163–167. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Curry JM, Sprandio J, Cognetti D,
Luginbuhl A, Bar-ad V, Pribitkin E and Tuluc M: Tumor
microenvironment in head and neck squamous cell carcinoma. Semin
Oncol. 41:217–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kondo T: Stem cell-like cancer cells in
cancer cell lines. Cancer Biomark. 3:245–250. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sääf AM, Halbleib JM, Chen X, Yuen ST,
Leung SY, Nelson WJ and Brown PO: Parallels between global
transcriptional programs of polarizing Caco-2 intestinal epithelial
cells in vitro and gene expression programs in normal colon and
coloncancer. Mol Biol Cell. 18:4245–4260. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Klonisch T, Wiechec E, Hombach-Klonisch S,
Ande SR, Wesselborg S, Schulze-Osthoff K and Los M: Cancer stem
cell markers in common cancers-therapeutic implications. Trends Mol
Med. 14:450–460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Leung EL, Fiscus RR, Tung JW, Tin VP,
Cheng LC, Sihoe AD, Fink LM, Ma Y and Wong MP: Non-small cell lung
cancer cells expressing CD44 are enriched for stem cell-like
properties. PLoS One. 5:e140622010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Valent P, Bonnet D, De Maria R, Lapidot T,
Copland M, Melo JV, Chomienne C, Ishikawa F, Schuringa JJ, Stassi
G, et al: Cancer stem cell definitions and terminology: The devil
is in the details. Nat Rev Cancer. 12:767–775. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Lin WC, Rajbhandari N and Wagner KU:
Cancer cell dormancy in novel mouse models for reversible
pancreatic cancer: A lingering challenge in the development of
targeted therapies. Cancer Res. 74:2138–2143. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Williams AB: Spontaneous mutation rates
come into focus in Escherichia coli. DNA Repair (Amst). 24:73–79.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Le Beyec J, Xu R, Lee SY, Nelson CM, Rizki
A, Alcaraz J and Bissell MJ: Cell shape regulates global histone
acetylation in human mammary epithelial cells. Exp Cell Res.
313:3066–3075. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Gazdar AF, Gao B and Minna JD: Lung cancer
cell lines: Useless artifacts or invaluable tools for medicine
science? Lung Cancer. 68:309–318. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Roschke AV, Tonon G, Gehlhaus KS, McTyre
N, Bussey KJ, Lababidi S, Scudiero DA, Weinstein JN and Kirsch IR:
Karyotypic complexity of the NCI-60 drug-screening panel. Cancer
Res. 63:8634–8647. 2003.PubMed/NCBI
|
|
63
|
Daniel VC, Marchionni L, Hierman JS,
Rhodes JT, Devereux WL, Rudin CM, Yung R, Parmigiani G, Dorsch M,
Peacock CD and Watkins DN: A primary xenograft model of small-cell
lung cancer reveals irreversible changes in gene expression imposed
by culture in vitro. Cancer Res. 69:3364–3373. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Gazdar AF, Bader S, Hung J, Kishimoto Y,
Sekido Y, Sugio K, Virmani A, Fleming J, Carbone DP and Minna JD:
Molecular genetic changes found in human lung cancer and its
precursor lesions. Cold Spring Harb Symp Quant Biol. 59:565–572.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Akunuru S, Zhai James Q and Zheng Y:
Non-small cell lung cncer stem/progenitor cells are enriched in
multiple distinct phenotypic subpopulations and exhibit plasticity.
Cell Death Dis. 3:e3522012. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Shultz LD, Ishikawa F and Greiner DL:
Humanized mice in translational biomedical research. Nature Rev
Immunol. 7:118–130. 2007. View Article : Google Scholar
|
|
67
|
Perumal D, Singh S, Yoder SJ, Bloom GC and
Chellappan SP: A novel five gene signature derived from stem-like
side population cells predicts overall and recurrence-free survival
in NSCLC. PLoS One. 7:e435892012. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Yeh CT, Su CL, Huang CY, Lin JK, Lee WH,
Chang PM, Kuo YL, Liu YW, Wang LS, Wu CH, et al: A preclinical
evaluation of antimycin a as a potential antilung cancer stem cell
agent. Evid Based Complement Alternat Med. 2013:9104512013.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Liu J and Mao Z, Huang J, Xie S, Liu T and
Mao Z: Blocking the NOTCH pathway can inhibit the growth of
CD133-positive A549 cells and sensitize to chemotherapy. Biochem
Biophys Res Commun. 444:670–675. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Xu Y, Jiang Z, Zhang Z, Sun N, Zhang M,
Xie J, Li T, Hou Y and Wu D: HtrA1 downregulation induces cisplatin
resistance in lung adenocarcinoma by promoting cancer stem
cell-like properties. J Cell Biochem. 115:1112–1121. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Bertolini G, Roz L, Perego P, Tortoreto M,
Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S,
et al: Highly tumorigenic lung cancer CD133+ cells exhibit
stem-like features and are spared by cisplatin treatment. Proc Natl
Acad Sci USA. 106:16281–16286. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Yao Q, Sun JG, Ma H, Zhang AM, Lin S, Zhu
CH, Zhang T and Chen ZT: Monitoring microRNAs using a molecular
beacon in CD133+/CD338+ human lung adenocarcinoma-initiating
A549cells. Asian Pac J Cancer Prev. 15:161–166. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Lin S, Sun JG, Wu JB, Long HX, Zhu CH,
Xiang T, Ma H, Zhao ZQ, Yao Q, Zhang AM, et al: Aberrant microRNAs
expression in CD133+/CD326+ human lung
adenocarcinoma initiating cells from A549. Mol Cells. 33:277–283.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Li Z, Xiang Y, Xiang L, Xiao Y, Li F and
Hao P: ALDH maintains the stemness of lung adenoma stem cells by
suppressing the notch/CDK2/CCNE pathway. PLoS One. 9:e926692014.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Kim IG, Kim SY, Choi SI, Lee JH, Kim KC
and Cho EW: Fibulin-3-mediated inhibition of
epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung
cancer stem cells through IGF1R signaling. Oncogene. 33:3908–3917.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zakaria N, Yusoff NM, Zakaria Z, Lim MN,
Baharuddin PJ, Fakiruddin KS and Yahaya B: Human non-small cell
lung cancer expresses putative cancer stem cell markers and
exhibits the transcriptomic profile of multipotent cells. BMC
Cancer. 15:842015. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Ghosh G, Lian X, Kron SJ and Palecek SP:
Properties of resistant cells generated from lung cancer cell lines
treated with EGFR inhibitors. BMC Cancer. 12:952012. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Levina V, Marrangoni AM, DeMarco R,
Gorelik E and Lokshin AE: Drug-selected human lung cancer stem
cells: Cytokine network, tumorigenic and metastatic properties.
PLoS One. 3:e30772008. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Shi Y, Fu X, Hua Y, Han Y, Lu Y and Wang
J: The side population in human lung cancer cell line NCI-H460 is
enriched in stem-like cancer cells. PLoS One. 7:e333582012.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Liu YP, Yang CJ, Huang MS, Yeh CT, Wu AT,
Lee YC, Lai TC, Lee CH, Hsiao YW, Lu J, et al: Cisplatin selects
for multidrug-resistant CD133+ cells in lung adenocarcinoma by
activating Notch signaling. Cancer Res. 73:406–416. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Shien K, Toyooka S, Yamamoto H, Soh J,
Jida M, Thu KL, Hashida S, Maki Y, Ichihara E, Asano H, et al:
Acquired resistance to EGFR inhibitors is associated with a
manifestation of stem cell-like properties in cancer cells. Cancer
Res. 73:3051–3061. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Jaggupilli A and Elkor E: Significance of
CD44 and CD24 as cancer stem cell markers: An enduring ambiguity.
Clin Dev Immunol. 2012:7080362012. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Teng Y, Wang X, Wang Y and Ma D:
Wnt/beta-catenin signaling regulates cancer stem cells in lung
cancer A549 cells. Biochem Biophys Res Commun. 392:373–379. 2010.
View Article : Google Scholar : PubMed/NCBI
|
